HomeNews and MediaCompany News

News and Media

Company News
Shanghai Haini PharmaceuticalHeld its 10th Anniversary Ceremony
Author: Date:2013/8/1 17:56:00 Read:2454
On September 11, Shanghai Haini Pharmaceutical Co., Ltd. of YRPG held its 10th anniversary ceremony. Leaders of Shanghai Municipal and other departments and managers of YRPG and the subsidiary attended the ceremony towitness the glorious moment.
Xu Jianguang, Vice Secretary of party committee of Shanghai Health Bureau and Director of Food and Drug Administration, Chen Yiguo, Vice Secretary of party committee and mayor of Zhoupu Town, Xu Jingren, YRPG Chairman, Xu Ying, Chairman ofHainiPharmaceutical, and Luo Jun, General Manager of Haini Pharmaceutical,addressed the opening ceremony.
Xu Jianguang congratulated Haini Pharmaceuticalfor its achievements generated from the company'squality control and constant products innovation since establishment. He saidHaini Pharmaceutical should see quality as thelife of the enterprise. Haini Pharmaceutical should intensify quality control and self-control, continuously provide quality health services and contribute to publish health.
YRPGChairman Xu Jingren reviewed Haini pharmaceutical's ten years in hisspeech. The sales revenue of Haini Pharmaceutical increased from less than ten million yuan in 2002 to more than one billion yuan in 2010. Haini Pharmaceutical has undergone a splendid development. He hoped in the Twelfth Five-Year Plan period Haini Pharmaceutical could transform the mode of economic development, increase itsindependent innovationability, develop new drugs and make unremitting effortsfor the vision and mission of the next decade.
Chen Yiguo congratulated Haini Pharmaceutical's achievements on behalf of Zhoupu Town, and expressed his appreciation for Haini Pharmaceutical's contribution inpromoting local economic development and creating jobs. He hopedHaini Pharmaceutical could further utilizethe geographical advantage, strengthen R&D, enlarge production scale, increase employment, and constantly create tax revenue, so as to achieve win-win resultsfor enterprise and the region.
Luo Jun, General Manager of Haini Pharmaceutical, reviewed the enterprise'sdevelopment course of ten years.In recent years, Haini Pharmaceutical has always been adhering to the enterprise principle of "Seeking progress all the time and safeguarding health for all human being", and sticking to the philosophy of "Strengthening enterprises through science and technology". The Company has formulated the R&D strategy of "three superior and one feature".In 2003, Haini Pharmaceutical Post-Doctoral Research Center was established.In 2004, Haini Institute of Medicine was established. The Institute has introduced more than ten pharmaceutical and chemical doctors from Shanghai Jiaotong University, PekingUniversity, Tsinghua University, Chinese Academy of Sciences, and other well-known universities, and also established cooperative relationships with Columbia University, Chinese Academy of Sciences, Fudan University and China Pharmaceutical University and other domestic and overseas academic institutes.Haini Pharmaceuticalsuccessively developed Landi, Tianli, Haichao and other star products with technological content, added value and efficacy.Since their access into the market, the products have yielded remarkable economic and social benefits.Landi, the remarkable drug of cardiovascular class, created the sale revenue of RMB 350 million, ranking top among the domestic brandsfor high blood pressure.Tianlihadthe annual sales revenue reachingnearly 260 million and was rated Shanghai Key New Product. A new generation of fluoroquinolones antibacterialdrugGatifloxacinwon the "National Key New Product" title. HainiPharmaceutical also won a series of remarkable awards, such as Shanghai High-Tech Enterprise, Shanghai Enterprise Technical Center, Shanghai AAA Creditworthy Enterpriseand so on. Haini Pharmaceutical stressed to establishitshuman-oriented and creditworthy enterprise culture, creating a sound image for the enterpriseand contributing to a harmonious society. LuoJun said that,in the future,Shanghai Haini Pharmaceutical, the first subsidiary of YRPG, wouldbe dedicated to shouldering the mission of rejuvenatingnational medicine and taking the lead in development.
In the celebration, Xu Ying, Chairman of Haini Pharmaceutical, launched the steering ceremony with local government officials, whichimplied that Haini Pharmaceutical wassetting off at the new starting point, from which, Haini Pharmaceutical will,being human-oriented, trustworthy andresponsiblefor nation, society, enterprise, family and employees, charge ahead for new excellency.
After the opening ceremony, Shanghai Haini Pharmaceutical presented a splendid banquet and wonderful entertainment programs. The galaHainiDreams ofFuture consisted of dances, instrumental performance, and traditional operas, etc. Finally,Chairman Xu Jingren and guests injected champagne into the ice sculpture, wishing Haini Pharmaceutical a bright future.